{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-23-000005","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2023-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.581300+00:00","generated_at":"2026-06-20T05:47:21.297675+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Stryker Q4 organic sales +13.2%, adj. EPS $3.00; FY23 adj. EPS guide $9.85-10.15","bullets":["Q4 reported sales $5.2B (+10.7% YoY); organic sales +13.2% driven by MedSurg and Neurotechnology (+16.9% organic).","Q4 reported EPS $1.47 (-15.0%); adjusted EPS $3.00 (+10.7%) – includes $216M goodwill impairment in Spine.","Full-year sales $18.4B (+7.8% reported); organic sales +9.7%; adjusted EPS $9.34 (+2.8%).","2023 outlook: organic sales growth 7.0-8.5%; adjusted EPS $9.85-$10.15.","Adjusted operating margin contracted 70 bps in Q4 to 26.6% and 180 bps for FY to 23.8%."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-23-000005","json":"https://secwatch.observer/filing/0000310764-23-000005.json","markdown":"https://secwatch.observer/filing/0000310764-23-000005.md","text":"https://secwatch.observer/filing/0000310764-23-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076423000005/0000310764-23-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076423000005/syk-20230131.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T05:47:21.297675+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1837449ae099f2c40da837325c90abd879b4db4e","claim":"STRYKER CORP reported 2023 outlook results: EPS $9.85 to $10.15. Guidance initiated.","evidence_excerpt":"We expect 2023 organic net sales growth (2) to be in the range of 7.0% to 8.5% and expect adjusted net earnings per diluted share (2) to be in the range of $9.85 to $10.15.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/310764/000031076423000005/0000310764-23-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"2023 outlook"},{"label":"EPS","value":"$9.85 to $10.15"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"e33898961ba014c3a0d14c7348e93d6f099b7310","claim":"STRYKER CORP reported Full year 2022 results: revenue $18.4 billion, net income $3.6 billion, EPS $9.34.","evidence_excerpt":"Full Year Results • Reported net sales increased 7.8% to $18.4 billion • Organic net sales increased 9.7% • Reported operating income margin of 15.4% • Adjusted operating income margin (1) contracted 180 bps to 23.8% • Reported EPS increased 18.4% to $6.17 • Adjusted EPS (1) increased 2.8% to $9.34","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/310764/000031076423000005/0000310764-23-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full year 2022"},{"label":"Revenue","value":"$18.4 billion"},{"label":"Net income","value":"$3.6 billion"},{"label":"EPS","value":"$9.34"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e33898961ba014c3a0d14c7348e93d6f099b7310","claim":"STRYKER CORP reported Full year 2022 results: revenue $18.4 billion, net income $3.6 billion, EPS $9.34.","evidence_excerpt":"% (3.7) % 19.3 % 2.4 % 16.9 % Orthopaedics and Spine 4.3 (4.0) 8.3 (0.1) 8.4 Total 10.7 % (3.8) % 14.5 % 1.3 % 13.2 % Full Year Results • Reported net sales increased 7.8% to $18.4 billion • Organic net sales increased 9.7% • Reported operating income margin of 15.4% • Adjusted operating income margin (1) contracted 180 bps to 23.8% • Reported EPS increased 18.4%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/310764/000031076423000005/0000310764-23-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full year 2022"},{"label":"Revenue","value":"$18.4 billion"},{"label":"Net income","value":"$3.6 billion"},{"label":"EPS","value":"$9.34"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e8e119468f0cd9832844c6563f14186e81046b36","claim":"STRYKER CORP reported Fourth quarter 2022 results: revenue $5.2 billion, net income $1.1 billion, EPS $3.00.","evidence_excerpt":"Fourth Quarter Results • Reported net sales increased 10.7% to $5.2 billion • Organic net sales increased 13.2% • Reported operating income margin of 15.6% • Adjusted operating income margin (1) contracted 70 bps to 26.6% • Reported EPS decreased 15.0% to $1.47 • Adjusted EPS (1) increased 10.7% to $3.00","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/310764/000031076423000005/0000310764-23-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Fourth quarter 2022"},{"label":"Revenue","value":"$5.2 billion"},{"label":"Net income","value":"$1.1 billion"},{"label":"EPS","value":"$3.00"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e8e119468f0cd9832844c6563f14186e81046b36","claim":"STRYKER CORP reported Fourth quarter 2022 results: revenue $5.2 billion, net income $1.1 billion, EPS $3.00.","evidence_excerpt":"- January 31, 2023 - Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2022: Fourth Quarter Results • Reported net sales increased 10.7% to $5.2 billion • Organic net sales increased 13.2% • Reported operating income margin of 15.6% • Adjusted operating income margin (1) contracted 70 bps to 26.6% • Reported EPS decreased 15.0%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/310764/000031076423000005/0000310764-23-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Fourth quarter 2022"},{"label":"Revenue","value":"$5.2 billion"},{"label":"Net income","value":"$1.1 billion"},{"label":"EPS","value":"$3.00"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}